Muutke küpsiste eelistusi

E-raamat: Difficult Decisions in Endocrine Surgery: An Evidence-Based Approach

Edited by , Edited by
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 135,23 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Difficult Decisions in Endocrine Surgery: An Evidence-Based ApproachSuurem pilt
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book provides a comprehensive overview of difficult decisions encountered within endocrine surgery. Brief uniformly formatted chapters are devoted to answering specific questions relevant to a range of topics across endocrine surgery based upon detailed analysis of available evidence.Topics covered include clinical decision analysis, decision making from the surgeon’s and patient’s perspective, using surgery as opposed to observation for papillary thyroid microcarcinoma, and the use of parathyroid cryopreservation. 

Difficult Decisions in Endocrine Surgery: An Evidence-Based Approach features a wealth of information on ideal approaches for making clinical decisions in selected clinical situations. It is an important and timely resource for all endocrine surgical trainees, fellows, practitioners, educators, and healthcare providers involved in the management of these patients. 

Arvustused

This book provides up-to-date recommendations in clinical decision making for common clinical scenarios in endocrine surgery where the recommended management strategy is not always straightforward. It provides a well-organized summary of current literature with easy-to-follow tables summarizing pertinent data from the studies used to support the authors' recommendations. It is an excellent resource for endocrine surgeons and trainees to maintain/develop an evidence-based practice. (Anna C Beck, Doody's Book Reviews, February, 2019)

1 Evidence-Based Medicine and the GRADE Approach 1(12)
Sadeesh K. Srinathan
2 Clinical Decision Analysis 13(10)
Sadeesh K. Srinathan
Feng Xie
3 Decision-Making from the Surgeon's Perspective 23(14)
Karen Devon
4 Involving Patients in Difficult Decisions About Having Surgery 37(12)
Joshua A. Hemmerich
Kellie Van Voorhis
Mark K. Ferguson
5 Surgery vs Active Surveillance for Low-Risk Papillary Thyroid Carcinoma 49(10)
Benjamin R. Roman
Ashok R. Shaha
6 Prospective Screening Protocol for FNMTC Family Members: Ultrasound Versus Physical Examination 59(10)
Insoo Suh
Jesse Pasternak
7 Operative Management Versus Observation for Thyroid Nodules Larger than 4 cm with Benign Cytology 69(10)
Nicole A. Cipriani
8 Lobectomy Versus Total Thyroidectomy for Follicular Microcarcinomas 79(8)
Linwah Yip
9 Initial Total Thyroidectomy Versus Lobectomy with Intraoperative Frozen Section for Thyroid Nodules That Are "Suspicious for PTC" 87(18)
Jason A. Glenn
Tracy S. Wang
10 Primary Repair Versus No Repair for Transected Recurrent Laryngeal Nerve 105(10)
Alexander Langerman
Cheryl C. Nocon
11 Surgery Versus Observation for Papillary Thyroid Microcarcinoma 115(8)
Shi Lam
Brian H.H. Lang
12 First-Line Therapy for Anaplastic Thyroid Cancer: Operation Versus Medical Management 123(18)
Shabirhusain Abadin
Paritosh Suman
Jessica Hwang
Anu Thakrar
Subhash Patel
13 Same-Day Versus Overnight Inpatient Surgery for Total Thyroidectomy 141(12)
Abbas Al-Kurd
Haggi Mazeh
14 Prophylactic Versus Selective Central Neck Dissection in Pediatric Papillary Thyroid Cancer 153(10)
Benjamin James
Raymon H. Grogan
Edwin L. Kaplan
Peter Angelos
15 Subtotal Parathyroidectomy Versus Total Parathyroidectomy with Autotransplantation for Patients with Multiple Endocrine Neoplasia 1 and Primary Hyperparathyroidism 163(16)
Terry C. Lairmore
16 Four-Gland Exploration Versus Four-Dimensional Computed Tomography in Patients with Nonlocalized Primary Hyperparathyroidism 179(14)
Courtney E. Quinn
Tobias Carling
17 Lymph Node Dissection Versus No Lymph Node Dissection for Parathyroid Cancer 193(16)
Reese W. Randle
David F. Schneider
18 Early Versus Late Parathyroidectomy for Tertiary (Posttransplant) Hyperparathyroidism 209(8)
Jyotirmay Sharma
Collin Weber
19 Observation Versus Surgery for Pregnant Patients with Primary Hyperparathyroidism 217(10)
James Y. Lim
James A. Lee
20 Four-Gland Exploration Versus Focused Parathyroidectomy for Hyperparathyroidism Jaw Tumor Syndrome 227(12)
Dhaval Patel
Electron Kebebew
21 Long-Term Success of Surgery for Primary Hyperparathyroidism: Focused Exploration using Intraoperative Parathyroid Hormone Monitoring Versus Four-Gland Exploration 239(34)
Wesley Barnes
Peter F. Czako
Sapna Nagar
22 The Evidence for and Against Parathyroid Cryopreservation: Should We Continue to Promote Parathyroid Cryopreservation?. 273(10)
Selyne Samuel
Marlon A. Guerrero
23 Should Antibiotic Prophylaxis Be Given Prior to Thyroidectomy or Parathyroidectomy? 283(8)
Jacob Moalem
24 The Value of Intraoperative Parathyroid Hormone Monitoring in Primary Hyperparathyroidism Cases That Are Localized with Two Imaging Studies 291(10)
Jennifer H. Kuo
Wen T. Shen
25 Transperitoneal Versus Retroperitoneal Laparoscopic Adrenalectomy 301(10)
Amudhan Pugalenthi
Eren Berber
26 Bilateral Adrenalectomy Versus Medical Management for Cushing's Syndrome with Bilateral Adrenal Hyperplasia 311(14)
Colleen Majewski
27 Routine Screening for Primary Hyperaldosteronism in Hypertensive Patients: Yes or No? 325(12)
Konstantinos P. Economopoulos
Carrie C. Lubitz
28 Routine Glucose Monitoring in Postoperative Pheochromocytoma Patients: Yes or No? 337(12)
Neha Goel
James A. Lee
29 Surgical Versus Nonsurgical Management of Malignant Pheochromocytoma 349(12)
Mark S. Cohen
Travis M. Cotton
30 Alpha Blocker Versus Calcium Channel Blocker for Pheochromocytoma 361(14)
Elizabeth Holt
Jennifer Malinowski
Glenda G. Callender
31 Surgery Versus Nonsurgical Therapy for Recurrent Adrenocortical Carcinoma 375(20)
Zahraa Al-Hilli
Melanie L. Lyden
32 Resection Versus Observation for Adrenal Gland Metastasis 395(18)
Frederic Mercier
Liane S. Feldman
Elliot J. Mitmaker
33 Routine Versus Selective Adrenal Vein Sampling for Primary Aldosteronism 413(10)
Sarah C. Oltmann
Alan Dackiw
Fiemu E. Nwariaku
34 Surgery Versus Observation for Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors 423(8)
Carlos R. Cordon-Fernandez
Miguel F. Herrera
35 Routine Lymph Node Dissection Versus Duodenal Inspection Alone for the Treatment of Multiple Endocrine Neoplasia Type 1 Patients with Hypergastrinemia 431(10)
Paxton V. Dickson
36 Resection Versus Chemotherapy for Metastatic Neuroendocrine Tumors of the Pancreas 441(18)
Kathleen K. Christians
George Younan
Ben George
Susan Tsai
Douglas B. Evans
37 Observation Versus Surgery for Nonlocalized Insulinoma 459(12)
Anthony J. Chambers
Janice L. Pasieka
Index 471
Dr. Peter Angelos is a highly regarded surgeon with extensive experience in surgery of the thyroid, parathyroid, and adrenal glands. He is particularly adept in treating endocrine cancers, including thyroid, parathyroid, and adrenocortical cancers and islet cell tumors of the pancreas. Dr. Angelos also has extensive expertise in medical ethics, and serves as associate director of the University of Chicago MacLean Center for Clinical Medical Ethics.  Dr. Raymon H. Grogan is a nationally respected board certified surgeon practising in Houston, Texas with a particular interest in Endocrine Surgery. He is the co-author of several national guidelines on endocrine surgery. He is also a pioneer of several novel techniques for operating on the thyroid and parathyroid and is one of only a handful of specialists on Transoral Endocrine Surgery in the USA. In 2017 he was awarded the prestigious Paul LoGerfo Research Grant from the American Association of Endocrine Surgeonsto study the relationship between the human microbiome and thyroid disease.
Lisainfo e-raamatute kohta Lisainfo e-raamatute kohta
Püsilink: https://www.kriso.ee/db/97833199286096e.html